Glenmark Pharmaceuticals informs about press release

08 Jan 2016 Evaluate

Glenmark Pharmaceuticals has informed about a Press Release dated January 08, 2016 titled ‘Glenmark announces the Discovery and Initiation of IND-enabling studies of a novel bi-specific monoclonal antibody targeting CD38’.

The above information is a part of company’s filings submitted to BSE.

Glenmark Pharma Share Price

2094.30 -6.00 (-0.29%)
02-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1694.65
Dr. Reddys Lab 1217.60
Cipla 1193.40
Zydus Lifesciences 864.25
Lupin 2276.80
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×